1. FRI0054 A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (interim analysis). (1st June 2001) Authors: Willis, RF; Pedersen, R Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗